SE8602723L - Tiazoler, deras framstellning och farmaceutiska kompositioner innehallande dem - Google Patents
Tiazoler, deras framstellning och farmaceutiska kompositioner innehallande demInfo
- Publication number
- SE8602723L SE8602723L SE8602723A SE8602723A SE8602723L SE 8602723 L SE8602723 L SE 8602723L SE 8602723 A SE8602723 A SE 8602723A SE 8602723 A SE8602723 A SE 8602723A SE 8602723 L SE8602723 L SE 8602723L
- Authority
- SE
- Sweden
- Prior art keywords
- tiazoles
- preparation
- pharmaceutical compositions
- compositions containing
- psychogeriatric
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000001430 anti-depressive effect Effects 0.000 abstract 1
- 230000002932 anti-schizophrenic effect Effects 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 239000002249 anxiolytic agent Substances 0.000 abstract 1
- 230000000949 anxiolytic effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- -1 psychogeriatric Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 150000003557 thiazoles Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3522353 | 1985-06-22 | ||
DE3522354 | 1985-06-22 | ||
DE3522351 | 1985-06-22 | ||
DE3605868 | 1986-02-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
SE8602723D0 SE8602723D0 (sv) | 1986-06-18 |
SE8602723L true SE8602723L (sv) | 1986-12-23 |
Family
ID=27433378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8602723A SE8602723L (sv) | 1985-06-22 | 1986-06-18 | Tiazoler, deras framstellning och farmaceutiska kompositioner innehallande dem |
Country Status (17)
Country | Link |
---|---|
US (2) | US4737500A (sv) |
AU (1) | AU5894086A (sv) |
BE (1) | BE904945A (sv) |
CH (1) | CH668426A5 (sv) |
DK (1) | DK292986A (sv) |
ES (2) | ES8802154A1 (sv) |
FI (1) | FI862644A (sv) |
FR (1) | FR2587342A1 (sv) |
GB (1) | GB2177395B (sv) |
GR (1) | GR861601B (sv) |
HU (1) | HUT43600A (sv) |
IL (1) | IL79178A0 (sv) |
IT (1) | IT1203806B (sv) |
LU (1) | LU86487A1 (sv) |
NL (1) | NL8601494A (sv) |
PH (1) | PH23389A (sv) |
SE (1) | SE8602723L (sv) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4804663A (en) * | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
NL8601494A (nl) * | 1985-06-22 | 1987-01-16 | Sandoz Ag | Thiazolen, hun bereiding en farmaceutische preparaten die ze bevatten. |
MX173362B (es) * | 1987-03-02 | 1994-02-23 | Pfizer | Compuestos de piperazinil heterociclicos y procedimiento para su preparacion |
FR2612187B1 (fr) * | 1987-03-12 | 1989-07-21 | Sanofi Sa | Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant |
US4804751A (en) * | 1987-06-30 | 1989-02-14 | American Home Products Corporation | Polycyclic hydrocarbon succinimides with psychotropic activity |
DE3877470T2 (de) * | 1987-09-10 | 1993-06-24 | Merck Sharp & Dohme | Oxazole und thiazole zur behandlung seniler demenz. |
US4883795A (en) * | 1988-01-22 | 1989-11-28 | Pfizer Inc. | Piperazinyl-heterocyclic compounds |
EP0350145A3 (en) * | 1988-04-28 | 1990-07-04 | Yamanouchi Pharmaceutical Co. Ltd. | Pyridylthiazolidine carboxamide derivatives and their intermediates and production of both |
US4935424A (en) * | 1988-05-27 | 1990-06-19 | Warner-Lambert Company | 4 or 5-(substituted piperazinylalkyl)-2-aminothiazoles as antipsychotic agents |
US5015740A (en) * | 1988-08-05 | 1991-05-14 | Janssen Pharmaceutica N.V. | Antipsychotic 3-piperazinylbenzazole derivatives |
US4957916A (en) * | 1988-08-05 | 1990-09-18 | Janssen Pharmaceutica N.V. | Antipsychotic 3-piperazinylbenzazole derivatives |
HUT61760A (en) * | 1988-09-16 | 1993-03-01 | Pfizer | Process for producing bridged, bicyclic imides comprising 4-/4-(3-benzisothiazolyl)-1-piperazinyl/-butyl group and pharmaceutical compositions comprising such compounds |
US4954503A (en) * | 1989-09-11 | 1990-09-04 | Hoechst-Roussel Pharmaceuticals, Inc. | 3-(1-substituted-4-piperazinyl)-1H-indazoles |
US5194436A (en) * | 1991-01-10 | 1993-03-16 | Hoechst-Roussel Pharmaceuticals Inc. | 1-piperazinyl-2-butenes and -2-butynes |
US5130315A (en) * | 1991-01-10 | 1992-07-14 | Raymond R. Wittekind | 1-piperazinyl-2-butenes and -2-butynes |
IT1251144B (it) * | 1991-07-30 | 1995-05-04 | Boehringer Ingelheim Italia | Derivati del benzimidazolone |
SK282231B6 (sk) * | 1993-11-19 | 2001-12-03 | Janssen Pharmaceutica N. V. | Farmaceutický prostriedok na liečenie psychotických porúch |
US5889010A (en) * | 1995-05-18 | 1999-03-30 | Pfizer Inc. | Benzimidazole derivatives having dopaminergic activity |
DE19746612A1 (de) | 1997-10-22 | 1999-04-29 | Basf Ag | 2-Substituierte 1,2-Benzisothiazol-Derivate, ihre Herstellung und Verwendung |
US7183410B2 (en) | 2001-08-02 | 2007-02-27 | Bidachem S.P.A. | Stable polymorph of flibanserin |
US20030060475A1 (en) * | 2001-08-10 | 2003-03-27 | Boehringer Ingelheim Pharma Kg | Method of using flibanserin for neuroprotection |
UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
US20050239798A1 (en) * | 2004-04-22 | 2005-10-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for the treatment of premenstrual and other female sexual disorders |
BRPI0510074A (pt) * | 2004-04-22 | 2007-10-16 | Boehringer Ingelheim Int | composições farmacêuticas para o tratamento de distúrbios sexuais ii |
US20060025420A1 (en) * | 2004-07-30 | 2006-02-02 | Boehringer Ingelheimn International GmbH | Pharmaceutical compositions for the treatment of female sexual disorders |
JP2008511569A (ja) * | 2004-09-03 | 2008-04-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 注意欠如活動過多障害の治療方法 |
EP1858515A2 (en) * | 2005-03-04 | 2007-11-28 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders |
WO2006096439A2 (en) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases |
WO2006096435A1 (en) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of depression |
EP1904182A2 (en) * | 2005-05-06 | 2008-04-02 | Boehringer Ingelheim International GmbH | Method for the treatment of drug abuse with flibanserin |
EP1888071A1 (en) * | 2005-05-19 | 2008-02-20 | Boehringer Ingelheim International GmbH | Method for the treatment of drug-induced sexual dysfunction |
JP2009503020A (ja) | 2005-08-03 | 2009-01-29 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 肥満症の治療におけるフリバンセリンの使用 |
US20070123540A1 (en) * | 2005-10-29 | 2007-05-31 | Angelo Ceci | Sexual desire enhancing medicaments comprising benzimidazolone derivatives |
EP1945214A1 (en) | 2005-10-29 | 2008-07-23 | Boehringer Ingelheim International GmbH | Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
US20070105869A1 (en) * | 2005-11-08 | 2007-05-10 | Stephane Pollentier | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders |
EA200802208A1 (ru) * | 2006-05-09 | 2009-04-28 | Бёрингер Ингельхайм Интернациональ Гмбх | Применение флибансерина для лечения расстройств полового влечения в постклимактерический период |
EP2037927B1 (en) * | 2006-06-30 | 2010-01-27 | Boehringer Ingelheim International GmbH | Flibanserin for the treatment of urinary incontinence and related diseases |
JP2009543839A (ja) * | 2006-07-14 | 2009-12-10 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 女性の性的障害を治療するためのフリバンセリンの使用 |
CL2007002214A1 (es) | 2006-08-14 | 2008-03-07 | Boehringer Ingelheim Int | Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp |
BRPI0716439B8 (pt) | 2006-08-14 | 2021-05-25 | Boehringer Ingelheim Int | sistemas de liberação farmacêutico compreendendo flibanserina, processo para preparação e uso dos mesmos |
CN101505736A (zh) | 2006-08-25 | 2009-08-12 | 贝林格尔.英格海姆国际有限公司 | 控制释放系统及其制造方法 |
PL2159226T3 (pl) * | 2007-03-29 | 2017-02-28 | Joint-Stock Company "Obninsk Chemical Pharmaceutical Company" | Środek antyhistaminowy i antyalergiczny oraz sposób jego wytwarzania |
UY31335A1 (es) * | 2007-09-12 | 2009-04-30 | Tratamiento de sintomas vasomotores | |
CA2686480A1 (en) | 2008-12-15 | 2010-06-15 | Boehringer Ingelheim International Gmbh | New salts |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL297170A (sv) * | 1963-04-04 | 1900-01-01 | ||
DE1595923A1 (de) * | 1965-02-20 | 1969-11-27 | Merck Ag E | 1-Aralkyl-4-(thiazolyl-2)-piperazine und Verfahren zu ihrer Herstellung |
BE759371A (fr) * | 1969-11-24 | 1971-05-24 | Bristol Myers Co | Azaspirodecanediones heterocycliques et procedes pour leur preparation |
JPS5246935B1 (sv) * | 1971-04-06 | 1977-11-29 | ||
BE787059A (fr) * | 1971-08-03 | 1973-02-01 | Wander Ag Dr A | Nouveaux derives du thiazole, leur preparation et leur application comme medicaments |
CH583232A5 (sv) * | 1973-02-02 | 1976-12-31 | Wander Ag Dr A | |
US4182763A (en) * | 1978-05-22 | 1980-01-08 | Mead Johnson & Company | Buspirone anti-anxiety method |
US4423049A (en) * | 1981-12-28 | 1983-12-27 | Mead Johnson & Company | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines |
DE3321969A1 (de) * | 1983-06-18 | 1984-12-20 | Troponwerke GmbH & Co KG, 5000 Köln | 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
NL8601494A (nl) * | 1985-06-22 | 1987-01-16 | Sandoz Ag | Thiazolen, hun bereiding en farmaceutische preparaten die ze bevatten. |
-
1986
- 1986-06-09 NL NL8601494A patent/NL8601494A/nl not_active Application Discontinuation
- 1986-06-09 HU HU862433A patent/HUT43600A/hu unknown
- 1986-06-12 CH CH2373/86A patent/CH668426A5/de not_active IP Right Cessation
- 1986-06-18 SE SE8602723A patent/SE8602723L/sv not_active Application Discontinuation
- 1986-06-18 BE BE1/011508A patent/BE904945A/fr not_active IP Right Cessation
- 1986-06-18 FR FR8608893A patent/FR2587342A1/fr active Pending
- 1986-06-19 GB GB8614974A patent/GB2177395B/en not_active Expired
- 1986-06-19 FI FI862644A patent/FI862644A/fi not_active IP Right Cessation
- 1986-06-20 ES ES556363A patent/ES8802154A1/es not_active Expired
- 1986-06-20 US US06/876,617 patent/US4737500A/en not_active Expired - Fee Related
- 1986-06-20 PH PH33910A patent/PH23389A/en unknown
- 1986-06-20 AU AU58940/86A patent/AU5894086A/en not_active Abandoned
- 1986-06-20 IL IL79178A patent/IL79178A0/xx unknown
- 1986-06-20 DK DK292986A patent/DK292986A/da not_active Application Discontinuation
- 1986-06-20 LU LU86487A patent/LU86487A1/fr unknown
- 1986-06-20 IT IT48157/86A patent/IT1203806B/it active
- 1986-06-20 GR GR861601A patent/GR861601B/el unknown
-
1987
- 1987-09-15 ES ES557723A patent/ES8802045A1/es not_active Expired
-
1988
- 1988-02-02 US US07/151,349 patent/US4892879A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DK292986D0 (da) | 1986-06-20 |
LU86487A1 (fr) | 1987-01-13 |
GB2177395A (en) | 1987-01-21 |
HUT43600A (en) | 1987-11-30 |
FI862644A0 (fi) | 1986-06-19 |
BE904945A (fr) | 1986-12-18 |
GB2177395B (en) | 1989-04-26 |
CH668426A5 (de) | 1988-12-30 |
SE8602723D0 (sv) | 1986-06-18 |
GR861601B (en) | 1986-10-20 |
ES8802154A1 (es) | 1988-04-01 |
NL8601494A (nl) | 1987-01-16 |
US4737500A (en) | 1988-04-12 |
ES556363A0 (es) | 1988-04-01 |
FR2587342A1 (fr) | 1987-03-20 |
US4892879A (en) | 1990-01-09 |
IL79178A0 (en) | 1986-09-30 |
PH23389A (en) | 1989-07-26 |
DK292986A (da) | 1986-12-23 |
GB8614974D0 (en) | 1986-07-23 |
ES8802045A1 (es) | 1988-03-16 |
IT8648157A0 (it) | 1986-06-20 |
AU5894086A (en) | 1986-12-24 |
ES557723A0 (es) | 1988-03-16 |
IT1203806B (it) | 1989-02-23 |
FI862644A (fi) | 1986-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8602723L (sv) | Tiazoler, deras framstellning och farmaceutiska kompositioner innehallande dem | |
ITFI930247A1 (it) | Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche. | |
FI872864A0 (sv) | Förfarande för framställning av farmaceutiskt aktiva bensimidazolföreningar | |
IT1213379B (it) | Tiazolo [4,5-c]chinoline, procedimento per la loro preparazione e composizioni farmaceutiche che le contengono. | |
KR890700125A (ko) | 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물 | |
DE3682083D1 (de) | Pharmazeutische zusammensetzungen. | |
IT1224405B (it) | Composti attivi sul sistema cardiovascolare | |
FI922806A (fi) | Substituerade 4-fenyl-4 -piperidinkarboxamider med baode lokalbedoevande och smaertstillande effekt samt foerfaranden foer deras framstaellning. | |
DE3674040D1 (de) | Pharmazeutische zusammensetzungen. | |
IT1256623B (it) | Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche | |
SE8302979L (sv) | Piperazinderivat, deras framstellning och farmaceutiska kompositioner innehallande dessa | |
SE8306225L (sv) | 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma | |
IT1197516B (it) | Derivati teofillinmetilanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono | |
IT8522327A0 (it) | Derivati macromolecolarizzati di cdp-colina, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono. | |
IT8721436A0 (it) | "derivati di 2,3,4,5,6,7 esaidro 2,7 metano 1,5 benzossazonina (rispettivamente 1,4 benzossazonina), procedimento per la loro preparazione e prodotti medicinali che contengono questi composti. | |
IT1201489B (it) | Derivati di tiazolidina,loro procedimento di preparazione e formulazioni farmaceutiche | |
SE8500822L (sv) | Diazepinoindoler, deras framstellning samt farmaceutiska kompositioner innehallande desamma | |
IT8821570A0 (it) | Impiego di derivati adenosinici per la preparazione di composizioni farmaceutiche aventi attivita' immunostimolante. | |
IT8520420A0 (it) | Sali di l-fosfoserina, procedimento per la loro preparazione e relative composizioni farmaceutiche. | |
IT1214540B (it) | Formulazioni idrosolubili di ubidecarenoni, procedimento per laloro preparazione e composizioni farmaceutiche che li compongono. | |
IT1205817B (it) | Benzammidi sostituite,procedimento per la loro preparazione e composizioni farmaceutiche che le contengono | |
IT1213568B (it) | Derivati imidazolici adattivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. | |
IT8619751A0 (it) | Composizioni farmaceutiche contenenti vinburnina e loro procedimento di preparazione. | |
IT1187729B (it) | Derivati fenilpiridinici,loro preparazione e relative formulazioni farmaceutiche | |
IT1224404B (it) | Composti attivi sul sistema cardiovascolare |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAV | Patent application has lapsed |
Ref document number: 8602723-2 Effective date: 19900810 |